Answers are grounded in this paper and cite their sources.
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.
No takes yet. Share an insight, caveat, or question.
Zellmer et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: